World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
79
Citations
24275
World Ranking
1208
National Ranking
33

Medicine

D-Index
86
Citations
29825
World Ranking
14038
National Ranking
462

Jason Grebely publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Jason Grebely sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 388 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Jason Grebely D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Jason Grebely sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 79 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Jason Grebely is affiliated with the University of New South Wales in Australia and has contributed extensively to research in medicine, with particular emphasis on epidemiology and hepatology. Their work concentrates on infectious diseases and public health, addressing topics such as hepatitis C virus research, HIV and drug use, and opioid use disorder treatment.

Their recent papers include:

  • Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study (2022), published in The Lancet. Gastroenterology & hepatology
  • Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence (2021), published in JAMA Psychiatry
  • Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review (2023), published in The Lancet Global Health
  • Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review (2023), published in The Lancet Global Health
  • Agreement between self-reported illicit drug use and biological samples: a systematic review and meta-analysis (2023), published in Addiction

Frequent coauthors include Gregory J. Dore, Behzad Hajarizadeh, Carla Treloar, Evan B. Cunningham, and Louisa Degenhardt.

Jason Grebely has published prolifically in journals such as International Journal of Drug Policy, The Lancet. Gastroenterology & hepatology, Journal of Hepatology, Drug and Alcohol Review, and SSRN Electronic Journal. Their major fields of study encompass medicine with a specialization in epidemiology, hepatology, infectious diseases, public health, and economics and econometrics applied to health contexts.

The primary topics covered in their research span:

  • Hepatitis C virus research
  • HIV, drug use, and sexual risk
  • Hepatitis B virus studies
  • Liver disease diagnosis and treatment
  • Opioid use disorder treatment
  • HIV/AIDS research and interventions
  • HIV/AIDS drug development and treatment

Best Publications

  • Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

    Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif

  • Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

    Louisa Degenhardt;Amy Peacock;Samantha Colledge;Janni Leung

  • Epidemiology and natural history of HCV infection

    Behzad Hajarizadeh;Jason Grebely;Gregory J. Dore

  • Global statistics on alcohol, tobacco and illicit drug use: 2017 status report

    Amy Peacock;Amy Peacock;Janni Leung;Sarah Larney;Sarah Larney;Samantha Colledge

  • Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.

    Unknown

  • Global patterns of opioid use and dependence: harms to populations, interventions, and future action.

    Louisa Degenhardt;Jason Grebely;Jack Stone;Matthew Hickman

  • Hepatitis C Virus Treatment for Prevention Among People Who Inject Drugs: Modeling Treatment Scale-Up in the Age of Direct-Acting Antivirals

    Natasha K. Martin;Peter Vickerman;Jason Grebely;Margaret Hellard

  • Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression

    Reem Waziry;Behzad Hajarizadeh;Jason Grebely;Janaki Amin

  • Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis.

    Thomas Santo;Brodie Clark;Matt Hickman;Jason Grebely

  • The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

    Jason Grebely;Kimberly A Page;Rachel Sacks-Davis;Martin Schim van der Loeff

  • Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States.

    Soumitri Barua;Robert Greenwald;Jason Grebely;Gregory J. Dore

  • Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review

    Sarah Larney;Amy Peacock;Janni Leung;Samantha Colledge

  • Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial

    Gregory J. Dore;Frederick Altice;Alain H. Litwin;Olav Dalgard

  • Treatment of Hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis

    Esther J Aspinall;Stephen Corson;Joseph S Doyle;Joseph S Doyle;Joseph S Doyle;Jason Grebely

  • Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

    Unknown

  • Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.

    Jason Grebely;Olav Dalgard;Brian Conway;Evan B Cunningham

  • Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine

    Jason Grebely;Maria Prins;Margaret Hellard;Andrea L Cox

  • Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs

    Jason Grebely;Sarah Larney;Amy Peacock;Samantha Colledge

  • Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.

    Unknown

  • Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.

    Jason Grebely;Kathy Petoumenos;Margaret Hellard;Margaret Hellard;Gail V. Matthews;Gail V. Matthews

  • Barriers associated with the treatment of hepatitis C virus infection among illicit drug users

    Jason Grebely;Jason Grebely;Krista A. Genoway;Krista A. Genoway;Jesse D. Raffa;Gurbir Dhadwal

  • Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis

    Behzad Hajarizadeh;Evan B Cunningham;Hannah Reid;Matthew Law

  • Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs

    Geert Robaeys;Geert Robaeys;Jason Grebely;Stefan Mauss;Philip Bruggmann

Frequent Co-Authors

Gregory J. Dore
Gregory J. Dore University of New South Wales
Margaret Hellard
Margaret Hellard Burnet Institute
Gail V. Matthews
Gail V. Matthews University of New South Wales
Andrew R. Lloyd
Andrew R. Lloyd University of New South Wales
Janaki Amin
Janaki Amin Macquarie University
Louisa Degenhardt
Louisa Degenhardt University of New South Wales
Matthew Hickman
Matthew Hickman University of Bristol
Lisa Maher
Lisa Maher University of New South Wales
Peter Vickerman
Peter Vickerman University of Bristol
Mel Krajden
Mel Krajden University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond traditional microbiology, several related online degrees offer promising career pathways. Health information management is a fast-growing field, and students can explore cahiim accredited health information management programs online to gain the necessary skills for managing healthcare data effectively.

Additionally, the healthcare industry demands professionals with proficiency in medical billing and coding. Fast online medical billing and coding certification programs provide a flexible and efficient way to enter this essential sector, often requiring less time to complete than traditional degrees.

For aspiring healthcare professionals, various medical programs online open doors to careers in nursing, allied health, and public health without the constraints of on-campus attendance. These programs cater to diverse interests within the medical field and offer more accessibility for working students.

Public health remains a vital area of focus linked closely with microbiology. Students looking for more accessible options can consider online mph programs easy to get into, designed to equip learners with the knowledge needed to influence community health policies and practices.

Best Scientists Citing Jason Grebely

Trending Scientists

Recently Published Articles